Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Allergy Clin Immunol. 2022 May 30;150(4):861–871. doi: 10.1016/j.jaci.2022.04.033

Table 1.

Demographic and clinical characteristics of the study groups

Healthy-Weight (n=49) Obese (n=40) P value
Demographics
Age (years) 8.79 ± 1.27 8.93 ± 1.37 NS
Male (n (%)) 27 (55.10) 24 (60.00) NS
Hispanic (n (%)) 29 (59.18) 27 (67.50) NS
Pulmonary function indices *
FVC 95.02 ± 13.01 103.23 ± 12.00 <0.01
FEV 1 91.41 ± 15.57 94.18 ± 16.55 0.42
FEV 1 /FVC ratio 84.24 ± 7.46 79.75 ± 8.33 0.01
FEF25–75% 79.27 ± 29.38 74.51 ± 29.05 0.48
TLC 93.36 ± 11.78 95.85 ± 13.99 0.38
RV 113.49 ± 31.49 100.43 ± 38.14 0.09
RV/TLC ratio 29.38 ± 5.90 24.80 ± 6.77 <0.01
ERV 88.36 ± 26.54 71.13 ± 19.15 <0.01
FRC 106.41 ± 22.91 90.38 ± 22.83 <0.01
IC 81.36 ± 13.14 98.73 ± 14.91 <0.01
Measures of asthma severity and control
CASI 7.95 ± 3.47 8.58 ± 3.20 0.38
ACT 19.58 ± 4.60 19.62 ± 4.53 0.97

All variables are reported as mean ± SD other than sex and ethnicity which are reported as proportions (n(%).

*

Pulmonary function indices are reported as percent-predicted values other than the ratios which are reported as percentages. A CASI score of greater than 3 is suggestive of higher asthma severity and an ACT score of 19 and higher is suggestive of good asthma control.